• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,236.23
  • 1.07 %
  • $86.96
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
agilon health, inc. (AGL) Stock Price, News & Analysis

agilon health, inc. (AGL) Stock Price, News & Analysis

Currency in USD Disclaimer

$1.79

$0.12

(6.89%)

Day's range
$1.64
Day's range
$1.82
50-day range
$1.5
Day's range
$4.21
  • Country: US
  • ISIN: US00857U1079
52 wk range
$1.5
Day's range
$13.76
  • CEO: Mr. Steven Jackson Sell
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 1.69
  • Piotroski Score 2.00
  • Grade Outperform
  • Symbol (AGL)
  • Company agilon health, inc.
  • Price $1.79
  • Changes Percentage (6.89%)
  • Change $0.12
  • Day Low $1.64
  • Day High $1.82
  • Year High $13.76

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

  • Last Earnings 11/04/2011
  • Ex-Dividend for 5/16 Dividend 11/16/2011
  • Dividend Payable 12/01/2011
  • Today N/A
  • Next Earnings (Estimated) 02/25/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $4.00
  • High Stock Price Target $6.50
  • Low Stock Price Target $2.50
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.49
  • Trailing P/E Ratio -13.88
  • Forward P/E Ratio -13.88
  • P/E Growth -13.88
  • Net Income $-262,596,000

Income Statement

Quarterly

Annual

Latest News of AGL

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

agilon health, inc. Frequently Asked Questions

  • What is the agilon health, inc. stock price today?

    Today's price of agilon health, inc. is $1.79 — it has increased by +6.89% in the past 24 hours. Watch agilon health, inc. stock price performance more closely on the chart.

  • Does agilon health, inc. release reports?

    Yes, you can track agilon health, inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the agilon health, inc. stock forecast?

    Watch the agilon health, inc. chart and read a more detailed agilon health, inc. stock forecast to see what analysts suggest you do with its shares.

  • What is agilon health, inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NYSE, exchange stock trades by agilon health, inc. stock ticker.

  • How to buy agilon health, inc. stocks?

    Like other stocks, AGL shares are sold on stock exchanges such as NYSE. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is agilon health, inc.'s EBITDA?

    agilon health, inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in agilon health, inc.’s financial statements.

  • What is the agilon health, inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -0.0608373299, which equates to approximately -6.08%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in agilon health, inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including agilon health, inc.'s financials relevant news, and technical analysis. agilon health, inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for agilon health, inc. stock currently indicates a “sell” signal. For more insights, review agilon health, inc.’s technical analysis.

  • A revenue figure for agilon health, inc. for its last quarter?

    agilon health, inc. published it's last quarterly revenues at $1.45 B.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.